Recurrence of Myocardial Disease in the Transplanted Heart

  • A. M. Keogh


The question of the potential for recurrence of the underlying disease in the cardiac allograft arises most frequently, in Westernized countries at least, in relation to amyloid and sarcoid heart disease and giant cell myocarditis. It is about these that the literature contains the most information. Far less information is available on disease recurrence in hemochromatosis, Chagas’ disease, and tumors involving the myocardium. One limitation of the literature is that follow-up is often relatively limited, particularly as the emphasis on results in cardiac transplantation is shifting away from 1-year survival towards long-term survival.


Familial Mediterranean Fever Cardiac Transplantation Cardiac Sarcoidosis Cardiac Amyloidosis Heart Lung Transplant 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Linke R. Therapy of amyloid diseases. Renal Failure. 1993;15:395–400.PubMedGoogle Scholar
  2. 2.
    Isobe T, Osscrman E. Patterns of amyloidosis and their association with plasma cell dyscrasia, monoclonal immunoglobulins and Bence-Jones proteins. N Engl J Med. 1974;290:473–7.PubMedGoogle Scholar
  3. 3.
    Kyle R, Bayrd E. Amyloidosis: review of 236 cases. Medicine. 1975;54:271–99.PubMedCrossRefGoogle Scholar
  4. 4.
    Buja L, Khoi N, Roberts W. Clinically significant cardiac amyloidosis: clinicopathologic findings in fifteen patients. Am J Cardiol. 1970;26:394–405.PubMedCrossRefGoogle Scholar
  5. 5.
    Cueto-Garcia L, Reeder G, Kyle R et al. Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol. 1985;6:737–43.PubMedGoogle Scholar
  6. 6.
    Roberts W, Waller B. Cardiac amyloidosis causing cardiac dysfunction: analysis of 54 necropsy patients. Am J Cardiol. 1983;52:137–46.PubMedCrossRefGoogle Scholar
  7. 7.
    Siqueira-Filho A, Cunha C, Tajik A et al. M-mode and two-dimensional echocardio-graphic features in cardiac amyloidosis. Circulation. 1982;63:188–96.Google Scholar
  8. 8.
    Child J, Levisman J, Abbasi A, Macalpin R. Echocardiographic manifestations of infiltrative cardiomyopathy. Chest. 1976;70:726–31.PubMedGoogle Scholar
  9. 9.
    Deng M, Park J, Ron-Chowdury R et al. Heart transplantation for restrictive car-diomyopathy: development of cardiac amyoidosis in preexisting monoclonal gammopathy. J Heart Lung Transplant. 1992;11:139–41.PubMedGoogle Scholar
  10. 10.
    Cassidy J. Cardiac amyloidosis: two cases with digitalis sensitivity. Ann Intern Med. 1961;55:989–94.PubMedGoogle Scholar
  11. 11.
    Gertz M, Falk R, Skinner M, Cohen A, Kyle R. Worsening of congestive cardiac failure in amyloid heart disease treated by calcium channel-blocking agents. Am J Cardiol. 1985;55:1645.PubMedCrossRefGoogle Scholar
  12. 12.
    Gertz M, Kyle R, Griepp P. Response rates and survival in primary systemic amyloi-dosis. Blood. 1990;77:257–62.Google Scholar
  13. 13.
    Sumeray M, Murday A. Pulmonary amyloidosis occurring after heart transplantation for amyloid heart disease. J Heart Lung Transplant. 1995; 14;2:402–3.PubMedGoogle Scholar
  14. 14.
    Hosenpud J, DeMarco T, Frazier H et al. Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Circulation. 1991;84(Suppl.III):III–338–43.Google Scholar
  15. 15.
    Conner R, Hosenpud J, Norman D et al. Heart transplantation for cardiac amyloidosis; successful one-year outcome despite recurrence of the disease. J Heart Transplant. 1988;7:165–7.PubMedGoogle Scholar
  16. 16.
    Hosenpud J, Uretsky B, Griffith B et al. Successful intermediate-term outcome for patients with cardiac amyloidosis undergoing heart transplantation: results of a multicenter survey. J Heart Lung Transplant. 1990;9:346–50.Google Scholar
  17. 17.
    Valantine H, Billingham M. Recurrence of amyloid in a cardiac allograft four months after transplantation. J Heart Transplant. 1989;8;4:337–41.PubMedGoogle Scholar
  18. 18.
    Silverman K, Hutchins G, Bukley B. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation. 1978;58;6:1204–11.PubMedGoogle Scholar
  19. 19.
    Gozo E, Cosnow I, Cohen H, Okun L. The heart in sarcoidosis. Chest. 1971;60:379.PubMedGoogle Scholar
  20. 20.
    Valantine H, Tazelaar H, Macoviak J et al. Cardiac sarcoidosis: response to steroids and transplantation. J Heart Transplant. 1987;6:244–50.PubMedGoogle Scholar
  21. 21.
    Lie J, Hunt D, Valantine P. Sudden death from cardiac sarcoidosis with involvement of conduction system. Am J Med Sci. 1974;267:123–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Miller A, Jackler I, Chuang M. Onset of sarcoidosis with left ventricular failure and multisystem involvement. Chest. 1976;70:302–4.PubMedGoogle Scholar
  23. 23.
    Roberts W, McAllister H, Ferrans V. Sarcoidosis of the heart: clinicopathologic study of 35 necropsy patients (group I); a review of 78 previously described necropsy patients (group II). Am J Med. 1977;63:76–108.CrossRefGoogle Scholar
  24. 24.
    Scadding J. Further observations on sarcoidosis associated with M. tuberculosis infection. In: Levinsky L, Macholda F, editors. Proceedings of the 5th International Conference on Sarcoidosis. Prague: Universita Karlova: 1971;89–93.Google Scholar
  25. 25.
    Lipsky B, Goldberger A, Tomkins L, Plorde J. Infections caused by non-diphtheria corynebacteria. Rev Infect Dis. 1982;4:1220–35.PubMedGoogle Scholar
  26. 26.
    Sodja J. Votava L. Isolation of haemadsorptive virus from cases of sarcoidosis. Acta Viral. (Prague) 1966;10:81.Google Scholar
  27. 27.
    Hills S, Parkes S, Baker S.Epidemiology of sarcoidosis in the Isle of Man. II: Evidence for space-time clustering. Thorax. 1987;42:427.PubMedGoogle Scholar
  28. 28.
    Ferrans V, Hibbs R, Black W, Walsh J, Burch G. Myocardial degeneration in cardiac sarcoidosis. Am Heart J. 1965;69:159–72.PubMedCrossRefGoogle Scholar
  29. 29.
    Sekiguchi M. Numao M, Imai M, Furuie T, Mikami R. Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis. Concepts through a study employing endomyocardial biopsy. I. Sarcoidosis. Jpn Circ. 1980;44:249–63.Google Scholar
  30. 30.
    Oni A, Hershberger R, Norman D et al. Recurrence of sarcoidosis in a cardiac allo-graft: control with augmented steroids. J Heart Lung Transplant. 1992; 11:367–9.PubMedGoogle Scholar
  31. 31.
    Auwerx J, Ector H, Demedts M. Sarcoidosis of the heart. Acta Clin Belg. 1983;38:303–10.Google Scholar
  32. 32.
    Bulkley B, Rouleau J, Whitaker J, Straus HG, Pitt B. The use of 201 thallium for myocardial perfusion imaging in sarcoid heart disease. Chest. 1977;72:27–32.PubMedGoogle Scholar
  33. 33.
    Fleming H. Sarcoid heart disease. Br Heart J. 1974;36:54–68.PubMedGoogle Scholar
  34. 34.
    Strauss G, Lawlon B, Wenzel F et al. Detection of covert myocardial sarcoidosis by scalene node biopsy. Chest. 1976;69:790.PubMedGoogle Scholar
  35. 35.
    Walsh M. Systemic sarcoidosis with refractory ventricular tachycardia and heart failure. Br Heart J. 1978;40:931–3.PubMedGoogle Scholar
  36. 36.
    Burke W, Kcogh A, Maloncy P et al. Transmission of sarcoidosis via cardiac trans-plantation. Lancet. 1990;336:1579.PubMedCrossRefGoogle Scholar
  37. 37.
    Mitchell D, Rees R. A transmissible agent from sarcoid tissue. Lancet. 1969;2:81.PubMedCrossRefGoogle Scholar
  38. 38.
    Davidoff R, Palacios I, Southern J et al. Giant cell versus lymphocytic myocarditis. A comparison of their clinical features and long-term outcomes. Circulation. 1991;83:953–61.PubMedGoogle Scholar
  39. 39.
    Fauci A. Haynes B, Katz P, Wolff S. Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983;98:76–85.PubMedGoogle Scholar
  40. 40.
    Cooper L. Berry G, Rizeq M, Schroedcr J. Giant cell myocarditis. J Heart Lung Transplant. 1995;14:394–401.PubMedGoogle Scholar
  41. 41.
    Inoue S, Shinohara F, Sakai T et al. Myocarditis and arrhythmia: a clinicopathological study of conduction system based on serial section in 65 cases. Jpn Circ. 1989;53:49–57.Google Scholar
  42. 42.
    Briganti E, Esmore D, Federman J. Bergin P. Successful heart transplantation in a patient with histologically proven giant cell myocarditis. J Heart Lung Transplant. 1993;12;5:880–1.PubMedGoogle Scholar
  43. 43.
    Gries W, Farkas D, Winters G, Costanzo-Nordin M. Giant cell myocarditis: first report of disease recurrence in the transplanted heart. J Heart Lung Transplant. 1992;11:370–4.PubMedGoogle Scholar
  44. 44.
    Lamelle C, Vanhaecke J, Van deWerf F et al. Cardiac transplantation in giant cell myocarditis. A case report. Acta Cardiologica. 1994;49:279–86.Google Scholar
  45. 45.
    Nieminen M, Salminen U-S, Taskinen E, Heikkila P, Partanen J. Treatment of serious heart failure by transplantation in giant cell myocarditis diagnosed by endomyocardial biopsy. J Heart Lung Transplant. 1994;13:543–5.PubMedGoogle Scholar
  46. 46.
    Grant S. Giant cell myocarditis in a transplanted heart. Eur Heart J. 1993;14:10:1437.PubMedGoogle Scholar
  47. 47.
    Funkhauser J. Thymoma associated with myocarditis and the LE cell phenomenon. Report of a casc. N Engl J Mcd. 1961;264:34–6.Google Scholar
  48. 48.
    Rob S, Choudhury G, Choudhury A. Giant cell myocarditis. Lancet. 1963;11:172–4.CrossRefGoogle Scholar
  49. 49.
    Hudson R. Giant cell myocarditis. Cardiovasc Pathol. 1970;3:820–3.Google Scholar
  50. 50.
    Kloin J. Pernicious anemia and giant cell myocarditis. New association. Am J Med. 1985;78:355–60.PubMedCrossRefGoogle Scholar
  51. 51.
    Wilson M, Barth R. Baker P. Unverferth D, Kolibash A. Giant cell myocarditis. Am J Med. 1985;79:647–52.PubMedCrossRefGoogle Scholar
  52. 52.
    Davics M, Pomerance A. Teare R.Idiopathic giant cell myocarditis: a distinctive clinicopathological entity. Br Heart J. 1975;37:192–5.Google Scholar
  53. 53.
    Costanzo-Nordin M. Silver M. O’Connell J. Scanlon P, Robinson J. Giant cell myo-carditis: dramatic hemodynamic and histologic improvement with immunosuppres-sive therapy. Eur Heart J. 1987;(Suppl. J):271–4.Google Scholar
  54. 54.
    McFalls E, Hosenpud J, McNulty J, Kron J, Nile N. Granulomatous myocarditis-diagnosis by endomyocardial biopsy and response to steroids in two patients. Chest. 1986;89:509–11.PubMedGoogle Scholar
  55. 55.
    Kong G, Madden B. Spyrou N et al. Response of recurrent giant cell myocarditis in a transplanted heart to intensive immunosupprcssion. Eur Heart J. 1991;12:554–7.PubMedGoogle Scholar
  56. 56.
    Cooper DKC, Schlesinger R, Shrago S, Zuhdi N. Heart transplantation for giant cell myocarditis. J Heart Transplant. 1994;13;3:555.Google Scholar
  57. 57.
    Wolfsohn A, Davies R, Smith CD, Walley V. Giant cell myocarditis-like appearance after transplantation: an atypical manifestation of rejection? J Heart Lung Transplant. 1994;13:4:731–3.PubMedGoogle Scholar
  58. 58.
    Buja L, Roberts W. Iron in the heart: etiology and clinical significance. Am J Med. 1971;51:209–21.PubMedCrossRefGoogle Scholar
  59. 59.
    Powell L. Does transplantation of the liver cure genetic hemochromatosis? J Hepatol. 1993;16:259–61.CrossRefGoogle Scholar
  60. 60.
    Farrell F, Nguyen M, Woodley S et al. Outcome of liver transplantation in patients with hemochromatosis. Hepatology. 1994;20:404–10.PubMedCrossRefGoogle Scholar
  61. 61.
    Short E, Winkle R, Billingham M. Myocardial involvement in idiopathic hemochro-matosis: morphologic and clinical improvement following venesection. Am J Med. 1981;70:1275–9.PubMedCrossRefGoogle Scholar
  62. 62.
    Dabestani A, Child J, Henze E et al. Primary hemochromatosis: anatomic and physiologic characteristics of the cardiac ventricles and their response to phle-botomy. Am J Cardiol. 1984;54:153–9.PubMedCrossRefGoogle Scholar
  63. 63.
    Westra W, Hruban R, Baughman K et al. Progressive hemochromatic cardiomyopathy despite reversal of iron deposition after liver transplantation. Am J Clin Pathol. 1993;99:39–44.PubMedGoogle Scholar
  64. 64.
    Niederau C, Fischer R, Sonnenberg A el al. Survival and causes of death in cirrhotic and noncirrhotic patients with primary hemochromatosis. N Engl J Med. 1985;313:1256–62.PubMedCrossRefGoogle Scholar
  65. 65.
    Jensen P, Bagger J, Jensen F et al. Heart transplantation in a case of juvenile hereditary hemochromatosis followed by MRI and endomyocardial biopsies. Eur J Hematol. 1993;51:199–205.Google Scholar
  66. 66.
    Higuchi M, Gutierrez P, Aiello V el al. Immunohistochemical characterization of infiltrating cells in human chronic Chagasic myocarditis: comparison with myocardial rejection process. Virchows Archiv A. Pathol Anat Histopathol. 1993;423:157–60.CrossRefGoogle Scholar
  67. 67.
    Bocchi E, Bellotti G, Uip D el al. Long-term follow-up after heart transplantation in Chagas’ disease. Transplant Proc. 1993;25:1329–30.PubMedGoogle Scholar
  68. 68.
    de Carvalho V, Fonseca F, de Oliveira E et al. Chronic active hepatitis and possible relationship with immunosuppressive therapy. Arquiv Brasil Cardiol. 1991;57:41–5.Google Scholar
  69. 69.
    Goldstein D, Mehmet C, Rose E, Fisher P, Michler R. Experience with heart trans-plantation for cardiac tumors. J Heart Lung Transplant. 1995; 14:383–6.Google Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • A. M. Keogh

There are no affiliations available

Personalised recommendations